Kyverna Therapeutics Funding: $170M Raised, Series B (2023)
Kyverna Therapeutics is based in Emeryville, California. It has raised $170M in total funding. Latest round: Series B. Backed by Northpond Ventures.
Kyverna Therapeutics funding overview
Kyverna Therapeutics is based in Emeryville, California. Kyverna Therapeutics has raised $170M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in January 2023. The round record for Kyverna Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include Northpond Ventures.
Kyverna Therapeutics at a glance
Total raised
$170M
Latest round
Series B
Latest round date
January 2023
Headquarters
Emeryville, California
Notable investors
Northpond Ventures
Frequently asked about Kyverna Therapeutics funding
How much has Kyverna Therapeutics raised?
Kyverna Therapeutics has raised $170M in total disclosed funding across the rounds on record.
Who has invested in Kyverna Therapeutics?
Northpond Ventures are named among the investors backing Kyverna Therapeutics.
What was the latest Kyverna Therapeutics funding round?
The most recent disclosed round is a Series B, announced in January 2023.
Where is Kyverna Therapeutics based?
Kyverna Therapeutics is based in Emeryville, California.
When did Kyverna Therapeutics last raise?
The last disclosed Kyverna Therapeutics round closed in January 2023 at Series B.
We update the Kyverna Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Emeryville and their backers are listed below.
